Status:
COMPLETED
A Study to Follow up Recurrence Rates of Actinic Keratoses One Year After Completion of Study 1487-IMIQ
Lead Sponsor:
MEDA Pharma GmbH & Co. KG
Conditions:
Actinic Keratoses
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to obtain recurrence rates and long-term safety data for patients who had been treating actinic keratoses on the face and scalp with 5 % Imiquimod Cream in a previous study...
Eligibility Criteria
Inclusion
- 100% clearance of Actinic Keratosis (AK) lesions in the 1487 IMIQ study
Exclusion
- used any treatments in the previous treatment area within 24 hours prior to the follow-up visit
Key Trial Info
Start Date :
April 1 2005
Trial Type :
OBSERVATIONAL
End Date :
November 1 2005
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT00189254
Start Date
April 1 2005
End Date
November 1 2005
Last Update
February 7 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.